MICHAEL FAVILA: Open Payments
NPI 1447781521 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 72 payments from 15 companies in 2025. Trend: 2023 $1,264 · 2024 $1,421 · 2025 $1,523
Food & beverage: $1,523
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $421 |
| Novo Nordisk Inc | 8 | $179 |
| AstraZeneca Pharmaceuticals LP | 8 | $177 |
| Orexo US, Inc. | 5 | $117 |
| Indivior Inc. | 5 | $112 |
| Radius Health, Inc. | 4 | $101 |
| Phathom Pharmaceuticals, Inc. | 5 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Exact Sciences Corporation | 2 | $57 |
| Lilly USA, LLC | 3 | $54 |
Products named: VRAYLAR, UBRELVY, AIRSUPRA, Zubsolv, SUBLOCADE, Tymlos, Rybelsus, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
